People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sigma Pharmaceuticals Ltd | — | Pharmaceuticals | Series B | $18.2M | $619.4M | 2009 |
John W Stocker AO at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John W Stocker AO on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Smith | 1 | 28 |
| Robert Ellis | 1 | 5 |
| Michael Long | 1 | 4 |
| William J. Scott | 1 | 2 |
| Ian Finlay | 1 | 2 |
| Elmo De Alwis | 1 | 1 |
| James Barrie | 1 | 1 |
| Sue Morgan Dethick | 1 | 1 |
| Jackie Toh | 1 | 1 |
| Steve Waller | 1 | 1 |
| Keith Jeffs | 1 | 1 |
| Brian Jamieson | 1 | 1 |
| Peter Tilley | 1 | 1 |
| Linda B Nicholls | 1 | 1 |
| David S Bayes | 1 | 1 |
| Craig Tomlinson | 1 | 1 |
| Geoffrey D W Curlewis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.